ArticleBMC cancer2017

Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).

I Ubink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.